A patient previously on dapagliflozin is now prescribed 5 units of regular insulin before each meal and 10–15 units of Lantus (insulin glargine) at bedtime; with an HbA1c of 8%, how should the insulin regimen be administered, what glucose targets should be aimed for, how can I determine if control is adequate, and why might post‑prandial glucose remain high 2–3 hours after meals?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimen Management for Type 2 Diabetes with HbA1c 8%

Your patient needs systematic titration of both basal and prandial insulin doses using a structured algorithm, with target fasting glucose 80–130 mg/dL and post-prandial glucose <180 mg/dL; the current 5 units of regular insulin is insufficient because post-prandial hyperglycemia requires aggressive prandial dose escalation by 1–2 units every 3 days based on 2-hour post-meal readings. 1, 2

How to Administer the Insulin Regimen

Basal Insulin (Lantus/Glargine) Administration

  • Administer 10–15 units of Lantus once daily at a consistent time (bedtime, dinner, or breakfast—all are equally effective). 3
  • Bedtime administration is standard, but morning or dinner dosing works equally well if more convenient for the patient. 4, 5
  • The key is consistency: inject at the same time every day. 3

Prandial Insulin (Regular Insulin) Administration

  • Inject 5 units of regular insulin 30 minutes before each meal (breakfast, lunch, dinner). 2
  • Regular insulin requires this 30-minute lead time to match the post-meal glucose rise.
  • The current dose is clearly inadequate given persistent post-prandial hyperglycemia. 6

Glycemic Targets (Goals)

Target ranges per American Diabetes Association guidelines: 1

  • Fasting/pre-meal glucose: 80–130 mg/dL (4.4–7.2 mmol/L)
  • Post-prandial glucose (2 hours after meals): <180 mg/dL (<10.0 mmol/L)
  • HbA1c goal: <7% (<53 mmol/mol)

Your patient's current HbA1c of 8% indicates inadequate control requiring dose intensification. 1

Systematic Titration Algorithm

Step 1: Optimize Basal Insulin First

  • Start with the current 10–15 units of Lantus at bedtime. 2
  • Check fasting glucose daily. 2
  • If fasting glucose >130 mg/dL: increase Lantus by 2 units every 3 days until fasting glucose reaches 80–130 mg/dL. 2
  • If hypoglycemia occurs (glucose <70 mg/dL): reduce Lantus by 10–20%. 2
  • Continue titrating until fasting glucose is consistently in target range. 2

Step 2: Intensify Prandial Insulin

Once fasting glucose is controlled, address post-prandial hyperglycemia: 2, 6

  • Check glucose 2 hours after each meal. 1
  • If 2-hour post-prandial glucose >180 mg/dL: increase that meal's regular insulin dose by 1–2 units every 3 days. 2
  • Start with the meal showing the highest post-prandial excursion (typically dinner). 2
  • The current 5 units is a starting dose; most patients require significantly more. 6

Step 3: Monitor for Over-Basalization

Warning signs that basal insulin is too high and prandial insulin too low: 2

  • Fasting glucose in target but post-prandial glucose consistently >180 mg/dL
  • Hypoglycemia between meals despite high post-meal glucose
  • Basal dose >0.5 units/kg/day without achieving HbA1c <7%

If these occur: stop increasing basal insulin and aggressively titrate prandial doses instead. 2

Why Post-Prandial Glucose Remains High

Your patient's persistent post-prandial hyperglycemia 2–3 hours after meals with only 5 units of regular insulin reflects severe insulin deficiency requiring much higher prandial doses. 6

Key Reasons:

  • 5 units is a minimal starting dose; most patients with HbA1c 8% require 10–20+ units per meal. 2, 6
  • Post-prandial glucose control is the primary determinant of achieving HbA1c <7% once fasting glucose is optimized. 6
  • Research shows that even with adequate basal insulin (fasting glucose 103–143 mg/dL), patients failing to reach HbA1c <7% consistently have post-prandial glucose >140 mg/dL. 6
  • The patient likely has significant beta-cell dysfunction (previously on dapagliflozin, now requiring insulin), necessitating aggressive prandial coverage. 7, 6

How to Know Blood Sugar is Getting Managed

Daily Monitoring Strategy:

  • Check fasting glucose every morning (target 80–130 mg/dL). 1
  • Check 2-hour post-prandial glucose after each meal (target <180 mg/dL). 1
  • Record all readings in a logbook to guide dose adjustments every 3 days. 2

Success Indicators:

  • Fasting glucose consistently 80–130 mg/dL 1
  • Post-prandial glucose consistently <180 mg/dL 1
  • No hypoglycemia episodes (glucose <70 mg/dL) 2
  • HbA1c <7% when rechecked in 3 months 1

Critical Safety Measures

  • Prescribe glucagon for emergency hypoglycemia treatment when initiating or intensifying insulin. 2
  • Educate on hypoglycemia symptoms: shakiness, sweating, confusion, hunger. 3
  • If glucose <70 mg/dL: consume 15 grams fast-acting carbohydrate (4 glucose tablets, 4 oz juice), recheck in 15 minutes. 2
  • Rotate injection sites within the same body region to prevent lipodystrophy. 3

Common Pitfalls to Avoid

Pitfall 1: Therapeutic Inertia

  • Do not leave doses unchanged for weeks if targets are not met. 2
  • Titrate every 3 days based on glucose patterns. 2

Pitfall 2: Over-Basalization

  • Do not keep increasing Lantus indefinitely if post-prandial glucose remains high. 2
  • Once fasting glucose is controlled, shift focus to prandial insulin escalation. 2, 6

Pitfall 3: Inadequate Prandial Dosing

  • 5 units per meal is rarely sufficient for HbA1c 8%. 6
  • Be prepared to increase prandial doses to 15–25 units per meal if needed. 2

Pitfall 4: Ignoring Post-Prandial Glucose

  • Fasting glucose alone does not predict HbA1c achievement. 6
  • Post-prandial control is essential and often requires aggressive prandial insulin titration. 6

Adjunctive Considerations

If HbA1c remains >7% after 3–6 months of optimized basal-bolus insulin (basal dose >0.5 units/kg/day, prandial doses maximized), consider adding a GLP-1 receptor agonist to the regimen rather than further insulin escalation. 2

The patient's prior dapagliflozin use suggests they may benefit from reintroduction of SGLT-2 inhibitor or addition of GLP-1 agonist once insulin doses are optimized, particularly if weight gain becomes problematic. 7, 8

Related Questions

Should I reduce my insulin glargine (Lantus) dose because my overnight blood glucose is 187 mg/dL?
My overnight blood glucose is elevated and fasting blood glucose is markedly elevated. I am currently on insulin glargine (Lantus) 24 units with a carbohydrate‑to‑insulin ratio of 1 unit per 8 g and a medium correction factor. How should I adjust my basal insulin dose, carbohydrate ratio, and correction factor?
How should total daily insulin dose be determined for an insulin‑naïve adult with type II diabetes and an HbA1c of 8 %, and what glucose targets define adequate diabetes control?
What nighttime glucose trajectory table is appropriate for an adult female with type 2 diabetes mellitus who had a bedtime glucose of 126 mg/dL at 11:30 PM after 12 units of Lantus (insulin glargine), the previous night had a bedtime glucose of 168 mg/dL with 16 units of Lantus and a fasting glucose of 132 mg/dL, and a hemoglobin A1c of 8%?
What overnight glucose pattern and basal insulin dose adjustment are recommended for an adult female with type 2 diabetes, bedtime blood glucose 126 mg/dL after 12 units of Lantus (insulin glargine), prior bedtime glucose 168 mg/dL after 16 units, morning glucose 132 mg/dL, HbA1c 8 %, and a 1:50 AM glucose reading of 96 mg/dL?
What symptoms and complications can a patient experience if the recurrent or superior laryngeal nerve is injured during thyroidectomy?
How should I adjust the treatment for an 11‑year‑old with ADHD and intermittent explosive disorder who is on methylphenidate (Ritalin) 10 mg twice daily and guanfacine 2 mg twice daily but remains aggressive and has insomnia?
What are the differential diagnoses for a lump in an arm or leg?
Why do continuous glucose monitors (CGMs) show readings that differ from finger‑stick blood glucose measurements?
What is the recommended management for a 24‑year‑old woman with polycystic ovary syndrome, hirsutism and irregular menstrual cycles who declines combined oral contraceptive pills?
Is concurrent use of methylphenidate, zolpidem, clonazepam, and acetaminophen‑codeine safe, and how should it be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.